Physician profile
Michael C Kim
NPI 1639146467
$2,012.99
in general payments reported to CMS, 2019-2025
16 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $649 · 2020: $18.63 · 2021: $173 · 2022: $218 · 2023: $185 · 2024: $319 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932 · Travel and Lodging: $22.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.98 |
| Travel and Lodging | $22.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $485.23 | 2019 | |
| Bausch & Lomb Americas INC. | $477.66 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Glaukos Corporation | $192.74 | 2022-2024 | Ce-Marked Kxla System |
| Sight Sciences, INC. | $173.33 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $165.09 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $94.73 | 2019-2022 | |
| Alcon Vision LLC | $86.18 | 2024 | Rocklatan |
| Biotissue Holdings INC. | $63.81 | 2024-2025 | |
| Aerie Pharmaceuticals, INC. | $47.30 | 2019 | |
| Abbvie INC. | $46.57 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.93 | 2019 | |
| Kala Pharmaceuticals, INC. | $39.68 | 2019 | |
| Ani Pharmaceuticals, INC. | $27.59 | 2025 | Purified Cortrophin Gel |
| Apellis Pharmaceuticals, INC. | $27.14 | 2025 | Syfovre |
| Oyster Point Pharma, INC. | $25.20 | 2024 | Tyrvaya |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $20.81 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.